Sanofi SA

Fda approves AstraZeneca, Sanofi shot that shields infants and toddlers versus RSV
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Visuals The Meals and Drug Administration on Monday accredited AstraZeneca and Sanofi‘s shot that guards infants and toddlers versus respiratory syncytial virus, which is the leading trigger of hospitalization between infants in the U.S. Nirsevimab is the initial shot authorised by the […]
Read More
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters Uninsured Americans pay nearly $98 on average for a vial of Eli Lilly‘s generic insulin, even after the company pledged to cut the product’s list price to $25 per vial, […]
Read More
JPMorgan reveals its ‘pecking order’ for the next 50 % which include these higher-yielding worldwide shares
JPMorgan has named a raft of European shares it explained as acquiring high yields, powerful harmony sheets and harmless dividends, this kind of as BT Group , Bayer and Sainsbury’s . In a July 3 be aware detailing its outlook for the second fifty percent of the calendar year, analysts led by Mislav Matejka stated: […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
Narisara Nami | Moment | Getty Images A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical […]
Read More
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Eli Lilly CEO Dave Ricks on Wednesday promised not to raise prices on the company’s existing insulin products again — the only executive to do so before a Senate Health Committee hearing on making the life-saving diabetes drug more affordable. Sen. Bernie Sanders, the committee’s chair, asked Ricks and the CEOs of Novo Nordisk and […]
Read More
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
In this photo illustration, an insulin pen manufactured by the Novo Nordisk company is displayed on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images News | Getty Images The top executives of the three drug companies that control 90% of the global insulin market will testify May 10 before the Senate Health […]
Read More
Senate legislation would cap insulin at $35 per month for people with private insurance
In this photo illustration, insulin pens manufactured by the Novo Nordisk company are displayed on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images Bipartisan Senate legislation introduced Friday would cap the price of insulin at $35 per month for people with private insurance. The bill, drafted by Sens. Jeanne Shaheen, D-N.H., and […]
Read More
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022. Benoit Tessier | Reuters Shares of Sanofi and Regeneron both jumped by more than 6% on Thursday after the pharmaceutical companies released promising data showing their […]
Read More